We have designed a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider.~The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.~Follow-up surveys will be given at 30, 60, and 90 days. These surveys will be collected by e-mail or follow-up calls from Datum Research, LLC, contract research organization.~Data collection for this study will be derived through the 4 patient surveys (initial, 30 day, 60 day, and 90 day) and the prescription written by the provider.~The survey study will enroll patients until December 31, 2014, or until sufficient numbers have been achieved.~Rahm Foundation will continue the study until:~Sufficient information has accumulated to meet the scientific objectives of the Study (i.e. numeric targets or effect size)~The feasibility of collecting sufficient information diminishes to unacceptable levels, poor enrollment, loss to follow-up and/or~Other methods of gathering appropriate information become achievable or are deemed preferable.~Datum Research will need to have access to the prescription to see what compound was prescribed.
This is a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider.~The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.